These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24992170)

  • 21. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.
    Gayrard N; Cacheux V; Iborra F; Mourad G; Argilés A
    Arch Pathol Lab Med; 2008 Jun; 132(6):965-73. PubMed ID: 18517280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.
    Moore LE; Jaeger E; Nickerson ML; Brennan P; De Vries S; Roy R; Toro J; Li H; Karami S; Lenz P; Zaridze D; Janout V; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Linehan WM; Merino M; Simko J; Pfeiffer R; Boffetta P; Hewitt S; Rothman N; Chow WH; Waldman FM
    Oncogenesis; 2012 Jun; 1(6):e14. PubMed ID: 23552698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.
    Bi M; Zhao S; Said JW; Merino MJ; Adeniran AJ; Xie Z; Nawaf CB; Choi J; Belldegrun AS; Pantuck AJ; Kluger HM; Bilgüvar K; Lifton RP; Shuch B
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2170-5. PubMed ID: 26864202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.
    Mitchell TJ; Turajlic S; Rowan A; Nicol D; Farmery JHR; O'Brien T; Martincorena I; Tarpey P; Angelopoulos N; Yates LR; Butler AP; Raine K; Stewart GD; Challacombe B; Fernando A; Lopez JI; Hazell S; Chandra A; Chowdhury S; Rudman S; Soultati A; Stamp G; Fotiadis N; Pickering L; Au L; Spain L; Lynch J; Stares M; Teague J; Maura F; Wedge DC; Horswell S; Chambers T; Litchfield K; Xu H; Stewart A; Elaidi R; Oudard S; McGranahan N; Csabai I; Gore M; Futreal PA; Larkin J; Lynch AG; Szallasi Z; Swanton C; Campbell PJ;
    Cell; 2018 Apr; 173(3):611-623.e17. PubMed ID: 29656891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.
    Smits KM; Schouten LJ; van Dijk BA; Hulsbergen-van de Kaa CA; Wouters KA; Oosterwijk E; van Engeland M; van den Brandt PA
    Clin Cancer Res; 2008 Feb; 14(3):782-7. PubMed ID: 18245539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis].
    Schraml P; Zhaou M; Richter J; Brüning T; Pommer M; Sauter G; Mihatsch MJ; Moch H
    Verh Dtsch Ges Pathol; 1999; 83():218-24. PubMed ID: 10714214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.
    Guinot A; Lehmann H; Wild PJ; Frew IJ
    J Pathol; 2016 Jul; 239(3):365-73. PubMed ID: 27126173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.
    Narimatsu T; Matsuura K; Nakada C; Tsukamoto Y; Hijiya N; Kai T; Inoue T; Uchida T; Nomura T; Sato F; Seto M; Takeuchi I; Mimata H; Moriyama M
    Cancer Med; 2015 Jan; 4(1):112-24. PubMed ID: 25315157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.
    Favazza L; Chitale DA; Barod R; Rogers CG; Kalyana-Sundaram S; Palanisamy N; Gupta NS; Williamson SR
    Mod Pathol; 2017 Nov; 30(11):1603-1612. PubMed ID: 28731045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
    Wang Z; Kim TB; Peng B; Karam J; Creighton C; Joon A; Kawakami F; Trevisan P; Jonasch E; Chow CW; Canales JR; Tamboli P; Tannir N; Wood C; Monzon F; Baggerly K; Varella-Garcia M; Czerniak B; Wistuba I; Mills G; Shaw K; Chen K; Sircar K
    Clin Cancer Res; 2017 Nov; 23(21):6686-6696. PubMed ID: 28710314
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome.
    Arai E; Ushijima S; Tsuda H; Fujimoto H; Hosoda F; Shibata T; Kondo T; Imoto I; Inazawa J; Hirohashi S; Kanai Y
    Clin Cancer Res; 2008 Sep; 14(17):5531-9. PubMed ID: 18765545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivative Chromosome 3 Loss from t(3;6)(q12;q14) Followed by Differential
    Mizutani K; Yokoi S; Sawada S; Sakamoto I; Kameyama K; Kamei S; Hirade K; Sugiyama S; Matsunaga K; Yamada T; Kato Y; Nishihara H; Ishihara S; Deguchi T
    Cancer Genomics Proteomics; 2022; 19(6):740-746. PubMed ID: 36316043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p.
    Brauch H; Pomer S; Hieronymus T; Schadt T; Löhrke H; Komitowski D
    World J Urol; 1994; 12(3):162-8. PubMed ID: 7951344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
    Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
    J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF1α is not a target of 14q deletion in clear cell renal cancer.
    Shenoy N
    Sci Rep; 2020 Oct; 10(1):17642. PubMed ID: 33077781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.